MicuRx, Cumencor Partner With Pfizer To Discover, Develop Antibiotics For Drug-Resistant Tuberculosis
As per the terms of the agreement, Pfizer is expected to provide an upfront payment, funding for the discovery and preclinical development of novel antibiotics to treat MDR-TB,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.